Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Mortality and Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure Who Are Treatment Candidates for SGLT-2 Inhibitors

Publication ,  Conference
Vaduganathan, M; Greene, SJ; Zhang, S; Chiswell, K; Devore, AD; Butler, J; Heidenreich, PA; Huang, J; Kittleson, MM; Maddox, KEJ
Published in: CIRCULATION
2021

Duke Scholars

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

2021

Volume

144

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vaduganathan, M., Greene, S. J., Zhang, S., Chiswell, K., Devore, A. D., Butler, J., … Maddox, K. E. J. (2021). Mortality and Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure Who Are Treatment Candidates for SGLT-2 Inhibitors. In CIRCULATION (Vol. 144).
Vaduganathan, Muthiah, Stephen J. Greene, Shuaiqi Zhang, Karen Chiswell, Adam D. Devore, Javed Butler, Paul A. Heidenreich, Joanna Huang, Michelle M. Kittleson, and Karen E Joynt Maddox. “Mortality and Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure Who Are Treatment Candidates for SGLT-2 Inhibitors.” In CIRCULATION, Vol. 144, 2021.
Vaduganathan M, Greene SJ, Zhang S, Chiswell K, Devore AD, Butler J, et al. Mortality and Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure Who Are Treatment Candidates for SGLT-2 Inhibitors. In: CIRCULATION. 2021.
Vaduganathan M, Greene SJ, Zhang S, Chiswell K, Devore AD, Butler J, Heidenreich PA, Huang J, Kittleson MM, Maddox KEJ. Mortality and Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure Who Are Treatment Candidates for SGLT-2 Inhibitors. CIRCULATION. 2021.

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

2021

Volume

144

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology